These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21971937)

  • 1. Prolactin-induced mammary tumorigenesis is not a rodent-specific response.
    Harvey PW
    Toxicol Pathol; 2011 Oct; 39(6):1020-2. PubMed ID: 21971937
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: analysis of pharmaceutical experience with decades of rat carcinogenicity testing. Introduction to article by Sistare et al.
    Morton D; Alden CL
    Toxicol Pathol; 2011 Jun; 39(4):715. PubMed ID: 21666102
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of tests in yeasts and fungi in the detection and evaluation of carcinogens.
    Parry JM
    IARC Sci Publ; 1999; (146):471-85. PubMed ID: 10353399
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
    Kirkland D; Aardema M; Müller L; Makoto H
    Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation research, genetic toxicology and environmental mutagenesis.
    Martus HJ; Suter W
    Mutat Res; 2009 Jan; 672(2):135. PubMed ID: 19056513
    [No Abstract]   [Full Text] [Related]  

  • 6. Carcinogenesis. Testing times for the tests.
    Hay A
    Nature; 1991 Apr; 350(6319):555-6. PubMed ID: 2017254
    [No Abstract]   [Full Text] [Related]  

  • 7. Short-term tests for defining mutagenic carcinogens.
    Waters MD; Stack HF; Jackson MA
    IARC Sci Publ; 1999; (146):499-536. PubMed ID: 10353401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medium-term bioassays in rats for rapid detection of the carcinogenic potential of chemicals.
    Shirai T; Hirose M; Ito N
    IARC Sci Publ; 1999; (146):251-72. PubMed ID: 10353390
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro mammalian cell genotoxicity assays: their use and interpretation.
    McGregor D
    Prog Clin Biol Res; 1990; 340B():159-69. PubMed ID: 2203003
    [No Abstract]   [Full Text] [Related]  

  • 10. Strategies for the identification of rodent carcinogens by in vitro short-term tests.
    Zeiger E
    Prog Clin Biol Res; 1990; 340D():261-71. PubMed ID: 2371299
    [No Abstract]   [Full Text] [Related]  

  • 11. Comet assay responses as indicators of carcinogen exposure.
    Anderson D; Yu TW; McGregor DB
    Mutagenesis; 1998 Nov; 13(6):539-55. PubMed ID: 9862185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of rodent carcinogenicity utilizing a battery of in vitro and in vivo genotoxicity tests.
    Kim BS; Margolin BH
    Environ Mol Mutagen; 1999; 34(4):297-304. PubMed ID: 10618179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophilicity of nongenotoxic carcinogens and genotoxic noncarcinogens as measured by the ke test.
    Bakale G; McCreary RD
    Prog Clin Biol Res; 1990; 340D():355-65. PubMed ID: 2371305
    [No Abstract]   [Full Text] [Related]  

  • 14. A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins.
    Kirkland D; Reeve L; Gatehouse D; Vanparys P
    Mutat Res; 2011 Mar; 721(1):27-73. PubMed ID: 21238603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opportunities for an alternative integrating testing strategy for carcinogen hazard assessment?
    Doktorova TY; Pauwels M; Vinken M; Vanhaecke T; Rogiers V
    Crit Rev Toxicol; 2012 Feb; 42(2):91-106. PubMed ID: 22141324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computer assisted short-term test battery design: some answers (reply to John Ashby's commentary in Environmental and Molecular Mutagenesis).
    Ennever FK; Rosenkranz HS
    Environ Mol Mutagen; 1988; 12(4):349-52. PubMed ID: 3191915
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of short-and medium-term tests for carcinogens and data on genetic effects in carcinogenic hazard evaluation. Consensus report.
    IARC Sci Publ; 1999; (146):1-18. PubMed ID: 10353381
    [No Abstract]   [Full Text] [Related]  

  • 18. A feasibility study: Can information collected to classify for mutagenicity be informative in predicting carcinogenicity?
    Petkov PI; Patlewicz G; Schultz TW; Honma M; Todorov M; Kotov S; Dimitrov SD; Donner EM; Mekenyan OG
    Regul Toxicol Pharmacol; 2015 Jun; 72(1):17-25. PubMed ID: 25792138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated approach to testing and assessment for predicting rodent genotoxic carcinogenicity.
    Petkov PI; Schultz TW; Donner EM; Honma M; Morita T; Hamada S; Wakata A; Mishima M; Maniwa J; Todorov M; Kaloyanova E; Kotov S; Mekenyan OG
    J Appl Toxicol; 2016 Dec; 36(12):1536-1550. PubMed ID: 27225589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaches to the risk assessment of genotoxic carcinogens in food: a critical appraisal.
    O'Brien J; Renwick AG; Constable A; Dybing E; Müller DJ; Schlatter J; Slob W; Tueting W; van Benthem J; Williams GM; Wolfreys A
    Food Chem Toxicol; 2006 Oct; 44(10):1613-35. PubMed ID: 16887251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.